C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/12 (2006.01) A61K 47/48 (2006.01) C07H 21/00 (2006.01) C07K 14/705 (2006.01) C07K 16/30 (2006.01) C07K 17/00 (2006.01) C12N 5/06 (2006.01) C12N 5/08 (2006.01) C12Q 1/00 (2006.01) C12Q 1/68 (2006.01) G01N 33/574 (2006.01) G01N 33/577 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2142989
This invention provides an IL-6 dependent B-cell lymphoma cell line designated DS-1 deposited with the American Type Culture Collection, wherein the cell line is reactive with a monoclonal antibody produced by a hybridoma cell line designated 10D2F6 deposited with the American Type Culture Collection. The invention also provides a purified antigen reactive with a monoclonal antibody produced by 10D2F6. The antigen also exists on DS-1. Also provided is a method of detecting the presence of an antigen-stimulated T-cell comprising detecting the presence of the antigen on a lymphocyte. In addition, the invention pro- vides a method of detecting the presence of a neoplastic cell comprising detecting the presence of the antigen on a cell which is not a normal T-cell.
Bock Glenn H.
Fleisher Thomas A.
Kurman Carole C.
Nelson David L.
Department Of Health & Human Services (the) United States Of America As Represented By The Secretary
Finlayson & Singlehurst
LandOfFree
A novel b-lymphoma cell line and antigen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with A novel b-lymphoma cell line and antigen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A novel b-lymphoma cell line and antigen will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2014213